Navigation Links
Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
Date:6/22/2009

estimates and projections made by management. Cordex intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Cordex are forward-looking statements, including, but not limited to, the statements regarding the timing and expected results of the ATPotent(TM) proof-of-concept clinical trial in Italy, the statements regarding the timing of ATPace(TM)'s expected entry into a pivotal Phase 2b/3 clinical trial for the treatment of paroxysmal supraventricular tachycardia, the timing of CDP-1050's expected commencement of a Phase 2 clinical trial for the treatment of heart failure, the expected results of the use of ATPace(TM) and the estimated PSVT market. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Such risks include the risk that the data derived from the trials may not be sufficient to support marketing of approval of the products, clinical trial for approval of ATPace(TM) and the Phase 2 clinical trial for our CDP-1050 may not be successful, the results of the clinical trial for ATPotent(TM) may not be as expected, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be successful, the market may not be as anticipated and that our technology may not lead to expected results including the development or the successful commercialization of technologies relating to the use of ATP or nitric oxide. Additional uncertainties and risks are described in Cordex's most recently filed SEC documents, such as its m
'/>"/>
SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
2. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
3. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
4. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
5. Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
6. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
7. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
8. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
9. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
10. Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
11. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... CHICAGO, Ill. , Sept. 19, 2014  The ... ABBV ) declared a quarterly cash dividend of $0.42 ... payable Nov. 17, 2014 to stockholders of record at ... About AbbVie AbbVie is a global, research-based biopharmaceutical ... company,s mission is to use its expertise, dedicated people ...
(Date:9/19/2014)... , Sept. 19, 2014  For Cloud Pharmaceuticals, ... design and development, partnering is an integral part ... to design new drugs and identify early stage, ... to further their development. The company also partners ... support this business model, Cloud Pharmaceuticals will be ...
(Date:9/19/2014)... 2014 Research and Markets has announced ... Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023" ... of this report, the human microbiome market is segmented by ... market is expected to be valued as $294 million in ... 22.3% within the forecast period of 2019-2023. The market is ...
Breaking Medicine Technology:Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... Ill., Jan. 5, 2011 Transilwrap ... plastics in the lamination, print, packaging, and industrial ... Inc., one of the largest and most diversified ... United States. This acquisition supports Transilwrap,s strategic growth ...
... 5, 2011 Luminex Corporation (Nasdaq: LMNX ... 29th Annual JP Morgan Healthcare Conference to be held ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) The investor ... officer, will begin at 10:00 a.m. Pacific time (1:00 ...
Cached Medicine Technology:Transilwrap Company Acquires Interfilm Holdings 2Luminex Corporation to Present at JP Morgan Healthcare Conference 2
(Date:9/20/2014)... (PRWEB) September 20, 2014 "As a nurse, ... their tanks," said an inventor from Tamaqua, Pa. "The reason ... on the backs of their chairs. My invention enables them ... the Kam Oxygen Sensor to make it easier to monitor ... the user knows when the tank is low. It allows ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Plumbing ... 3.1 out of 5, indicating a moderately favorable purchasing ... this score reflects current and future pricing trends that ... high prices. Other factors that negatively affect buyer power ... for construction and the moderate switching costs. Buyers benefit, ...
(Date:9/20/2014)... QueenBeeTickets.com is ready to offer discount Ariana Grande ... visit many cities in North America next year from ... , Click Here to view the inventory ... The star’s fans are not going to want to ... in a live performance. Ariana Grande concert tickets are ...
(Date:9/20/2014)... Final Cut Pro X Plugin developers ... Information theme for FCPX filmmakers. , “Fun, cool, and simple ... theme,” says Christina Austin, CEO of Pixel Film Studios. “It ... Information features easy to use controls that give the user ... the background color, color of each circle outline, the position ...
(Date:9/20/2014)... The first federal bellwether trial of a DePuy ... in the U.S. District Court, Northern District of Texas, ... the week opened in the DePuy Pinnacle Hip ... vice president, who discussed the clinical testing performed on ... According to Reuters, the executive stated that the Pinnacle ...
Breaking Medicine News(10 mins):Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4
... Centre for Addiction and Mental Health (CAMH) and researchers ... risk factor for acetaldehyde-related cancer. Heavy drinkers may ... sources. , Acetaldehyde is ubiquitous in daily life in ... inhaled from the air and tobacco smoke, ingested from ...
... based drug rehabilitation center announced today that they will serve ... LAUDERDALE, Fla., March 19 The Recovery Place, a ... served their 691st patient since inception in 2007. "We anticipate ... a testament to the expertise of our clinical team, word ...
... support for equivalent doses, automatic drug updates -SAN ... provider of wireless, handheld barcode point-of-care (BPOC) ... will present information about its industry-leading NDC matching ... & Exhibition in booth 1476.The new NDC matching ...
... and high-risk lifestyles are just some of the barriers ... their condition, according to a research review that covered ... , The study, published in the March issue ... Chronic Illness , shows that psychosocial, socioeconomic, physical, environmental ...
... climate causing stress and consumers feeling out of controlNEW YORK, ... more in control of their lives during times when finances ... Monitor, however, there is a significant gap between how much ... While 81% of consumers say being in control of their ...
... CHADDS FORD, Pa., March 19 Endo Pharmaceuticals (Nasdaq: ... tender offer by its wholly owned subsidiary, BTB Purchaser Inc., ... Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ). American Stock ... has advised Endo that, as of 5 p.m., New York ...
Cached Medicine News:Health News:Acetaldehyde in alcohol -- no longer just the chemical that causes a hangover 2Health News:The Recovery Place Helps Hundreds of Patients Through Drug and Alcohol Rehabilitation 2Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 2Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 3Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 4Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 5Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 3Health News:Weight Watchers(R) Expands Licensed Food Categories with Launch of New Baked Goods, Frozen Novelty and Cheese Products to Encourage a More Sensible Lifestyle 2Health News:Weight Watchers(R) Expands Licensed Food Categories with Launch of New Baked Goods, Frozen Novelty and Cheese Products to Encourage a More Sensible Lifestyle 3Health News:Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals 2
CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....
... Techno-Aide provides the highest level ... highest quality lead protective eyewear. ... + tolerance allowed. Mfg supervised by ... All lens meet or exceed standards ...
This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....
All New Ultra Pb Series Glasses...
Medicine Products: